Search

Search Constraints

You searched for: Author/Creator Picard, Orit

Search Results

1. Ashkenazi Jewish Origin Protects Against Formation of Antibodies to Infliximab and Therapy Failure. Issue 18 (May 2015)

2. Association Between Infliximab Drug and Antibody Levels and Therapy Outcome in Pediatric Inflammatory Bowel Diseases. Issue 4 (October 2018)

3. Comparable Immune Function Inhibition by the Infliximab Biosimilar CT-P13: Implications for Treatment of Inflammatory Bowel Disease. (12th November 2016)

5. Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels but not with clinical worsening. (March 2022)

8. Dose optimisation for Loss of Response to Vedolizumab— Pharmacokinetics and Immune Mechanisms. (10th April 2021)

9. Host transcriptome signatures in human faecal-washes predict histological remission in patients with IBD. Issue 10 (19th January 2022)

10. Individualized Dynamics in the Gut Microbiota Precede Crohn's Disease Flares. (July 2019)